Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
AIDS Behav ; 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38833064

ABSTRACT

HIV-related stigma is a well-documented barrier to HIV testing in South Africa, and may be particularly likely to create reluctance to test among South African men, who have reported feeling blamed for HIV by their partners and communities. The present study presents a novel expanded social network recruitment to HIV testing (E-SNRHT) intervention explicitly designed to reduce stigma as a barrier to testing by asking people to recruit anyone they know to testing, thus allowing them to avoid the potential for increased stigma and/or blame associated with direct risk partner recruitment, and helping to normalize openly discussing HIV among social networks. We examined baseline and 6-10-week follow-up data from a 2022-2023 randomized trial in KwaZulu-Natal, South Africa that recruited 110 individuals who had been newly diagnosed with HIV and randomly assigned them to recruit people to HIV testing either via the E-SNRHT intervention or via risk network recruitment. Participants in the E-SNRHT intervention reported significant decreases in anticipated and enacted HIV-related stigma between baseline and follow-up; and the E-SNRHT intervention was more effective at decreasing enacted HIV-related stigma than was risk network recruitment. Individuals newly diagnosed with HIV by the E-SNRHT intervention reported significant increases in social support between intervention enrollment and follow-up, and all of these individuals reported participating in positive conversations about HIV services with peers in the 6-10 weeks after intervention enrollment. These findings suggest that E-SNRHT is a potentially important strategy to reduce HIV-related stigma as a barrier to HIV testing among peer networks in KwaZulu-Natal.

2.
Prog Cardiovasc Dis ; 83: 92-96, 2024.
Article in English | MEDLINE | ID: mdl-38417768

ABSTRACT

Cardiorespiratory fitness (CRF), heavily influenced by physical activity (PA), represents a strong and independent risk factor for a wide range of health conditions, most notably, cardiovascular disease. Substantial disparities in CRF have been identified between white and non-white populations. These disparities may partly account for group differences in susceptibility to poor health outcomes, including non-communicable disease. Race and ethnic differences in CRF may partly be explained by social injustices rooted in persistent structural and systemic racism. These forces contribute to environments that are unsupportive for opportunities to achieve optimal CRF levels. This review aims to examine, through the lens of social justice, the inequities in key social ecological factors, including socioeconomic status, the built environment, and structural racism, that underly the systemic differences in CRF and PA in vulnerable communities. Further, this review highlights current public health initiatives, as well as opportunities in future research, to address inequities and enhance CRF through the promotion of regular PA.


Subject(s)
Cardiorespiratory Fitness , Exercise , Health Status Disparities , Social Determinants of Health , Social Justice , Humans , Social Determinants of Health/ethnology , Risk Assessment , Cardiovascular Diseases/ethnology , Cardiovascular Diseases/epidemiology , Systemic Racism , Race Factors , Risk Factors , Built Environment , Social Class
3.
Lymphat Res Biol ; 21(4): 359-365, 2023 08.
Article in English | MEDLINE | ID: mdl-36946918

ABSTRACT

Introduction: The reported incidences of breast cancer-related lymphedema (LE) affecting the arms vary greatly. Reason for this variability includes different diagnostic techniques used across studies. In the current study, we compared the accuracy of indocyanine green lymphography (ICG_L) and bioimpedance spectroscopy (BIS) in detecting LE before presentation of clinical signs. Methods and Results: Patients with no initial detectable signs of clinical LE of their arms after axillary lymph node dissection or removal of >5 lymph nodes on sentinel lymph node biopsy were included. Subclinical LE was defined as BIS values outside the normal range [(≥7 units (or >10 units)] or a 7-unit (or 10 unit) change between two measurements. We tracked ICG_L and BIS measurements for 133 potentially affected arms (n = 123). ICG_L detected signs of lymphatic flow disruption in 63 arms (47%). Based on the BIS value of 7 units, 60 arms (45%) had values outside the normal range. When using ICG_L-identified LE cases as true positives, BIS had a 54% accuracy (area under the curve [AUC] = 0.54) in detecting LE. Accuracy was 61% for subclinical LE symptoms when compared with ICG_L (AUC = 0.62). Both BIS and subclinical LE symptoms had <0.70 AUC-receiver characteristic operator curve, suggesting that BIS and development of subclinical LE symptoms are not adequate for identifying patients with subclinical LE. Conclusion: ICG_L is a reliable diagnostic tool for detecting early signs of lymphatic flow disruption in subclinical LE. Utilizing ICG_L to diagnose subclinical LE followed by a personalized treatment plan may provide patients the best chance of preventing disease progression.


Subject(s)
Breast Cancer Lymphedema , Breast Neoplasms , Lymphedema , Humans , Female , Indocyanine Green , Lymphography/methods , Breast Neoplasms/complications , Breast Neoplasms/surgery , Early Detection of Cancer/adverse effects , Lymphedema/diagnostic imaging , Lymphedema/etiology , Breast Cancer Lymphedema/diagnostic imaging , Breast Cancer Lymphedema/complications , Sentinel Lymph Node Biopsy/adverse effects , Spectrum Analysis
4.
Am Surg ; 89(1): 108-112, 2023 Jan.
Article in English | MEDLINE | ID: mdl-33876999

ABSTRACT

BACKGROUND: Upper extremity (UE) vascular injuries account for 18.4% of all traumatic vascular injuries. Arterial pressure index (API) use in lower extremity injuries to determine the need for further investigations is well established. However, due to collateral circulation in UEs, it is unclear if the same algorithm can be applied. The purpose of this study was to determine if APIs can be used to determine the need for computed tomography angiogram (CTA) in penetrating UE trauma. METHODS: All adult trauma patients with penetrating UE trauma and APIs from 2006 to 2016 were identified at 3 urban US level 1 trauma centers. Sensitivity, specificity, and positive and negative predictive values of APIs <.9 in detecting UE arterial injuries were calculated. RESULTS: During the 11-year study period, 218 patients met our inclusion criteria. Gunshot wounds comprised 76.6% and stab wounds 17.9%. Median injury severity score and API were 9 and 1, respectively. Seventy-two of our patients underwent evaluation with CTA. Of the injuries, the most common were thrombus or occlusion (46.7%), transection (23.1%), and dissection (15.4%), radiographically. Ultimately, 32 patients underwent surgical.


Subject(s)
Arm Injuries , Vascular System Injuries , Wounds, Gunshot , Wounds, Penetrating , Adult , Humans , Vascular System Injuries/diagnostic imaging , Vascular System Injuries/surgery , Arterial Pressure , Retrospective Studies , Wounds, Penetrating/diagnostic imaging , Wounds, Penetrating/surgery , Upper Extremity/diagnostic imaging , Upper Extremity/blood supply , Extremities/diagnostic imaging
5.
Rev. cuba. med. trop ; 74(2): e802, May.-Aug. 2022. tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1408907

ABSTRACT

RESUMEN Introducción: Los medios de colecta de muestras clínicas con capacidad de desnaturalizar virus reducen los riesgos de contagio durante el transporte y procesamiento. Objetivo: Emplear el medio de transporte de ácidos nucleicos (TAN) en muestras de exudado nasofaríngeo colectadas para el diagnóstico de SARS-CoV-2. Métodos: Se realizó un estudio experimental para demostrar la capacidad del medio de inactivar la infectividad viral. Se tomó como modelo de virus envuelto el virus Zika (VZk), cuyo nivel de bioseguridad es 2. Se evaluó el desempeño clínico del medio TAN para el diagnóstico de SARS-CoV-2. Se empleó una cepa del VZk propagada en la línea celular Vero y, previo a la infección de las células, el VZk se puso en contacto a intervalos de tiempo diferentes (2; 15 y 30 min) con el medio TAN puro; y luego se realizaron diluciones seriadas (10-1-10-4). La inactivación viral se evaluó por RT-PCR, en el sobrenadante y células colectadas, al culminar el periodo de propagación. El desempeño clínico del medio TAN se estimó tomando como referencia el CITOSWAB® VTM, en 30 exudados nasofaríngeos colectados para diagnóstico de la infección por SARS-CoV-2. Resultados: El VZk preservó su infectividad a diluciones del inóculo ≥ 10-2, independientemente del tiempo de contacto. La sensibilidad y especificidad clínica del medio TAN para el diagnóstico de SARS-CoV-2 fueron del 100 %, respectivamente. Conclusiones: Los resultados sugieren que muestras clínicas positivas a VZk en diluciones ≤ 10-1 del medio TAN pueden ser manipuladas de forma segura, lo que pudiera aplicarse potencialmente al diagnóstico molecular del SARS-CoV-2.


ABSTRACT Introduction: Collection media of clinical samples with the capacity to denature viruses reduce the risk of contagion during transportation and processing. Objective: To use the nucleic acids transport media (NATM) in nasopharyngeal swab samples collected for the diagnosis of SARS-CoV-2. Methods: An experimental study was conducted to demonstrate the medium capacity to inactivate viral infectivity. Zika virus (ZIKV), of biosafety level 2, was used as an enveloped virus model. The clinical performance of the NATM for the diagnosis of SARS-CoV-2 was evaluated. A ZIKV strain propagated in the Vero cell line was used and, prior to cells infection, ZIKV was in contact at different intervals (2; 15, and 30 min) with pure NATM; subsequently, serial dilutions (10-1-10-4) were performed. Viral inactivation was evaluated by RT-PCR in the supernatant and the collected cells when the propagation period was completed. CITOSWAB® VTM was used as reference to estimate the clinical performance of the NATM in 30 nasopharyngeal swabs collected for the diagnosis of SARS-CoV-2 infection. Results: ZIKV remained infectious at inoculum dilutions of ≥ 10-2, regardless of contact time. Clinical specificity and sensitivity of the NATM for the diagnosis of SARS-CoV-2 were 100%, respectively. Conclusions: Results suggest that ZIKV positive clinical samples at dilutions ≤ 10-1 of the NATM can be safely handled, which could potentially be applied to the molecular diagnosis of SARS-CoV-2.


Subject(s)
Humans
6.
Front Psychol ; 12: 687641, 2021.
Article in English | MEDLINE | ID: mdl-34267711

ABSTRACT

The seemingly intractable opioid epidemic compels researchers, the media, and families to better understand the causes and effects of this complex and evolving public health crisis. The effects of this crisis on people using opioids, maternal prenatal opioid exposure, and neonatal abstinence syndrome are well-documented, but less is known about the impact of caregivers' opioid use on children's health and well-being. One challenge to understanding the effects of parental opioid use disorder (OUD) on child and adolescent outcomes is the numerous interrelated pathways in which a child's health and well-being can be impacted. To better understand these dynamic relationships, we applied a systems mapping approach to visualize complex patterns and interactions between pathways and potential leverage points for interventions. Specifically, we developed a causal loop diagram system map to elucidate the complex and interconnected relationships between parental OUD, social determinants of health at the family and socio-environmental levels, family strengths, social supports, and possible adverse impacts on children's physical and mental health and risks for future substance misuse. The goals of this research are to (1) identify factors and dynamics that contribute to the relationship between parental OUD and children's health and well-being and (2) illustrate how systems mapping as a tool can aid in understanding the complex factors and dynamics of the system(s) that influence the well-being of children and their parents or primary caregivers.

7.
Rev. cuba. reumatol ; 21(3): e116, sept.-dic. 2019.
Article in Spanish | LILACS, CUMED | ID: biblio-1093840

ABSTRACT

La talalgia se define como la percepción de dolor localizado en el talón que anatómicamente corresponde al hueso calcáneo y a las partes blandas colaterales, constituye la causa más frecuente de consulta a los especialistas en pie y tobillo, identificando dos zonas de aparición del dolor, el dolor plantar y el dolor posterior, los que están directamente relacionados con la inervación de esa zona del pie, realizamos un análisis general para evaluar las opciones iniciales de tratamiento y las indicaciones fisioterapéuticas exponiendo nuestra opinión y experiencias(AU)


Talalgia is defined as the perception of localized pain in the heel that anatomically corresponds to the calcaneus bone and collateral soft tissue, is the most frequent cause of consultation with foot and ankle specialists, identifying two areas of pain appearance, pain plantar and subsequent pain, which are directly related to the innervation of that area of the foot, we perform a general analysis to evaluate the initial treatment options and physiotherapeutic indications exposing our opinion and experiences(AU)


Subject(s)
Humans , Male , Female , Calcaneus/physiopathology , Heel/physiopathology
8.
Rev. cuba. reumatol ; 21(3): e114, sept.-dic. 2019.
Article in Spanish | LILACS, CUMED | ID: biblio-1093839

ABSTRACT

La artritis reumatoide es la enfermedad inflamatoria más común en adultos con una alta prevalencia en la población general, invocando para su diagnóstico la presencia de al menos cuatro criterios de los orientados por el Colegio Americano de Reumatología, teniendo un papel protagónico en los últimos años la presencia de anticuerpos anti proteína citrulinada, así como los estudios de imágenes, que ayudan al diagnóstico de la artritis reumatoide temprana en el curso de los dos primeros años de evolución y sus orientaciones terapéuticas adecuadas, aspecto fundamental en la actualidad para evitar las lesiones erosivas irreversibles, que resultan en un marcado compromiso de la calidad de vida de los pacientes que la sufren, elementos que revisamos en este artículo de opinión(AU)


Rheumatoid arthritis is the most common inflammatory disease in adults with a high prevalence in the general population, invoking for its diagnosis the presence of at least four criteria of those guided by the American College of Rheumatology, having a leading role in recent years the presence of anti-citrullinated protein antibodies, as well as imaging studies, which help the diagnosis of early rheumatoid arthritis in the course of the first two years of evolution and its appropriate therapeutic orientations, a fundamental aspect nowadays to avoid irreversible erosive lesions , which result in a marked commitment to the quality of life of patients who suffer from it, elements that we review in this opinion article(AU)


Subject(s)
Humans , Male , Female , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/epidemiology , Arthritis, Rheumatoid/diagnostic imaging , Quality of Life , Anti-Citrullinated Protein Antibodies/analysis , Ecuador
9.
MMWR Morb Mortal Wkly Rep ; 68(34): 745-748, 2019 Aug 30.
Article in English | MEDLINE | ID: mdl-31465319

ABSTRACT

Surveillance of U.S. breastfeeding duration and exclusivity has historically reported estimates among all infants, regardless of whether they had initiated breastfeeding. These surveillance estimates have consistently shown that non-Hispanic black (black) infants are less likely to breastfeed, compared with other racial/ethnic groups.* Less is known about disparities in breastfeeding duration when calculated only among infants who had initiated breastfeeding, compared with surveillance estimates based on all infants. CDC analyzed National Immunization Survey-Child (NIS-Child) data for infants born in 2015 to describe breastfeeding duration and exclusivity at ages 3 and 6 months among all black and non-Hispanic white (white) infants, and among only those who had initiated breastfeeding. When calculated among all infants regardless of breastfeeding initiation, breastfeeding differences between black and white infants were 14.7 percentage points (95% confidence interval [CI] = 10.7-18.8) for any breastfeeding at age 3 months and were significantly different for both any and exclusive breastfeeding at both ages 3 and 6 months. Among only infants who had initiated breastfeeding, the magnitude of black-white differences in breastfeeding rates were smaller. This was most notable in rates of any breastfeeding at 3 months, where the percentage point difference between black and white infants was reduced to 1.2 (95% CI = -2.3-4.6) percentage points and was no longer statistically significant. Black-white disparities in breastfeeding duration result, in part, from disparities in initiation. Interventions both to improve breastfeeding initiation and to support continuation among black mothers might help reduce disparities.


Subject(s)
Black or African American/psychology , Breast Feeding/ethnology , Mothers/psychology , White People/psychology , Adult , Black or African American/statistics & numerical data , Breast Feeding/psychology , Breast Feeding/statistics & numerical data , Health Status Disparities , Humans , Infant , Mothers/statistics & numerical data , Time Factors , United States , White People/statistics & numerical data , Young Adult
10.
Drug Metab Dispos ; 47(7): 764-767, 2019 07.
Article in English | MEDLINE | ID: mdl-31028056

ABSTRACT

A tenable hypothesis is presented which explains disparities between older oral dl-MPH bioavailability data generated using chiral derivatization-gas chromatography versus more recent findings using chiral liquid chromatography. These disparities persist in current literature. The gas chromatographic methods found that the absolute bioavailability of d-MPH is 23% and that of l-MPH is 5% (i.e., 82% as the active d-isomer), while liquid chromatographic methods consistently report that approximately 99% of circulating MPH is d-MPH. Older methods used perfluoroacylated S-prolyl derivatizing agents which have a history of imprecision due to the susceptibility of the prolyl S-configuration to isomerize to the R-enantiomer. Accordingly, any R-prolyl impurity in the chiral derivatization reagent yields the (R,R,R)-MPH-prolyl diastereomer which, in being related as the opposite enantiomer of (S,S,S)-prolyl-MPH, co-elutes with l-(S,S)-MPH. This results in overestimation of the percent l-MPH at the expense of underestimating d-MPH. Unless compelling reasons exist to justify use of any chiral discriminators, less complex and less costly achiral analysis of plasma MPH appears appropriate for d-MPH quantitation since 99% exists as d-MPH. However, simultaneous plasma monitoring of d-MPH and l-MPH may be warranted when alterations in first-pass hepatic metabolism by carboxylesterase 1 (CES1) occurs. For example, (a) with transdermal dl-MPH delivery; (b) in cases of concomitant dl-MPH and a CES1 inhibitor, e.g., ethanol, which elevates l-MPH and d-MPH concentrations; (d) in forensic studies of intravenous or intranasal dl-MPH abuse; (e) were dl-MPH to be formulated as a free base sublingual product; or (f) as emerging advances in dl-MPH gene-dose effects warrant isomer correlations.


Subject(s)
Central Nervous System Stimulants/pharmacokinetics , Chromatography, Gas/methods , Methylphenidate/pharmacokinetics , Biological Availability , Humans
11.
Pharmacotherapy ; 39(6): 677-688, 2019 06.
Article in English | MEDLINE | ID: mdl-30351459

ABSTRACT

In 2000, the first biphasic modified-release (MR) formulation of methylphenidate (MPH) was approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). An immediate-release (IR) MPH pulse (22% of the dose) facilitates rapid onset of stimulant action, while the remaining MR portion of the dose provides for day-long duration of efficacy. A wide array of oral MR-MPH products has subsequently been approved that also allows for once-daily dosing, though each product is characterized by distinctive exposure time courses. This review compares each member of the current MPH armamentarium to assist in the rational selection of a specific MPH regimen for the individualized treatment of patients with ADHD. The IR portion of biphasic MPH formulations now ranges from 15%, 20%, 22%, 25%, 30%, and 37% IR-MPH, as well as a 50% IR-MPH product whose distinctly pulsatile time course closely resembles that of the pre-century "gold standard" twice-daily IR-MPH regimen. Further, transdermal, suspension, and orally disintegrating tablet products are now available to overcome any solid dosage form swallowing difficulties. Most of these formulations are racemic, though in 2001, a chiral switch drug IR-dexmethylphenidate (dexMPH) was approved, followed by biphasic MR-dexMPH (50% IR) in 2005. New U.S. Food and Drug Administration (FDA) partial area under the curve (pAUC) bioavailability metrics have improved discrimination between specific generic MR-MPH products. This has resulted in two Orange Book MR-MPH products being recoded from "AB" (i.e., meets necessary bioequivalence requirements) to "BX" (i.e., insufficient data to confirm bioequivalence). The metabolic drug interaction between MPH and alcohol, which increases MPH bioavailability, potentiates euphoric effects, and heightens abuse liability, is discussed. This review concludes with brief considerations of pharmacogenomic predictors of ADHD first-line drug selection, carboxylesterase allelic variants influencing interindividual MPH metabolism, and novel MPH formulations in the regulatory pipeline.


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Dexmethylphenidate Hydrochloride/pharmacokinetics , Dexmethylphenidate Hydrochloride/therapeutic use , Methylphenidate/pharmacokinetics , Methylphenidate/therapeutic use , Precision Medicine/methods , Central Nervous System Stimulants/pharmacokinetics , Central Nervous System Stimulants/therapeutic use , Delayed-Action Preparations/adverse effects , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/therapeutic use , Dexmethylphenidate Hydrochloride/adverse effects , Dosage Forms , Drug Administration Schedule , Humans , Methylphenidate/adverse effects
13.
PLoS One ; 7(1): e29929, 2012.
Article in English | MEDLINE | ID: mdl-22242190

ABSTRACT

Micro-RNAs (miRNAs) are small non-coding RNAs that regulate gene expression, mainly at mRNA post-transcriptional level. Functional maturation of most miRNAs requires processing of the primary transcript by Dicer, an RNaseIII-type enzyme. To date, the importance of miRNA function for normal organogenesis has been demonstrated in several mouse models of tissue-specific Dicer inactivation. However, the role of miRNAs in thyroid development has not yet been addressed. For the present study, we generated mouse models in which Dicer expression has been inactivated at two different stages of thyroid development in thyroid follicular cells. Regardless of the time of Dicer invalidation, the early stages of thyroid organogenesis, preceding folliculogenesis, were unaffected by the loss of small RNAs, with a bilobate gland in place. Nevertheless, Dicer mutant mice were severely hypothyroid and died soon after weaning unless they were substituted with T4. A conspicuous follicular disorganization was observed in Dicer mutant thyroids together with a strong down regulation of Nis expression. With increasing age, the thyroid tissue showed characteristics of neoplastic alterations as suggested by a marked proliferation of follicular cells and an ongoing de-differentiation in the center of the thyroid gland, with a loss of Pax8, FoxE1, Nis and Tpo expression. Together, our data show that loss of miRNA maturation due to Dicer inactivation severely disturbs functional thyroid differentiation. This suggests that miRNAs are mandatory to fine-tune the expression of thyroid specific genes and to maintain thyroid tissue homeostasis.


Subject(s)
Gene Deletion , Hypothyroidism/enzymology , Ribonuclease III/metabolism , Thyroid Gland/enzymology , Thyroid Gland/pathology , Thyroid Neoplasms/enzymology , Thyroid Neoplasms/pathology , Animals , Cell Dedifferentiation/genetics , Cell Proliferation , Down-Regulation/genetics , Enzyme Activation , Gene Expression Regulation, Developmental , Hypothyroidism/genetics , Integrases/metabolism , Mice , Mice, Transgenic , Organ Specificity/genetics , PAX8 Transcription Factor , Paired Box Transcription Factors/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ribonuclease III/genetics , Thyroid Gland/growth & development , Thyroid Neoplasms/genetics
14.
Mol Neurobiol ; 44(1): 111-21, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21710140

ABSTRACT

The potassium channel tetramerization domain-containing protein 7 (KCTD7) was named after the structural homology of its predicted N-terminal broad complex, tramtrack and bric à brac/poxvirus and zinc finger domain with the T1 domain of the Kv potassium channel, but its expression profile and cellular function are still largely unknown. We have recently reported a homozygous nonsense mutation of KCTD7 in patients with a novel form of autosomal recessive progressive myoclonic epilepsy. Here, we show that KCTD7 expression hyperpolarizes the cell membrane and reduces the excitability of transfected neurons in patch clamp experiments. We found the expression of KCTD7 in the hippocampal and Purkinje cells of the murine brain, an expression profile consistent with our patients' phenotype. The effect on the plasma membrane resting potential is possibly mediated by Cullin-3, as we demonstrated direct molecular interaction of KCTD7 with Cullin-3 in co-immunoprecipitation assays. Our data link progressive myoclonic epilepsy to an inherited defect of the neuron plasma membrane's resting potential in the brain.


Subject(s)
Ion Channel Gating/genetics , Myoclonic Epilepsies, Progressive/genetics , Neurons/metabolism , Potassium Channels/genetics , Action Potentials/physiology , Animals , Antibody Specificity , COS Cells , Cells, Cultured , Chlorocebus aethiops , Cullin Proteins/metabolism , Gene Expression Regulation , Hippocampus/metabolism , Hippocampus/pathology , Humans , Immunoprecipitation , Mice , Neurons/pathology , Olfactory Bulb/metabolism , Olfactory Bulb/pathology , Potassium Channels/metabolism , Protein Binding , Protein Multimerization , Protein Transport , Purkinje Cells/metabolism , Purkinje Cells/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism
15.
Cochabamba; s.n; dic. 2005. 98 p. mapas, tab, graf.
Thesis in Spanish | LIBOCS, LILACS, LIBOE | ID: biblio-1295989

ABSTRACT

El presente estudio se llevo a cabo motivado por la gran existencia de adolescentes consumidores de alcohol tanto varones como mujeres, observandose un incremento diario en especial en los estudiantes del nivel secundario y primeros cursos de la universidad. De acuerdo a los datos obtenidos en el estudio se pudo determinar que un 50 por ciento de los adolescentes de ambos sexos consumieron bebidas alcoholicas, mas en varones que en mujeres, y el consumo era esporadico, por lo que no llega a la clasificacion del abuso del alcohol. Los resultados de las encuestas muestran que tanto hombres y mujeres no tienen en su mayoria problemas relacionados al consumo, los problemas mas frecuentes son familiares y los escolares. El inicio del consumo de bebidas alcoholicas en mujeres es a los 15 años y en los hombres a los 16 años pero la diferencia es que los hombres tienen un consumo mas frecuente segun aumenta la edad y las mujeres mantienen el consumo esporadico en su mayoria


Subject(s)
Adolescent , Alcoholism , Bolivia , Prevalence
16.
16 de abril ; (221)2005. tab, graf
Article in Spanish | CUMED | ID: cum-33711

ABSTRACT

Se aplicaron dos encuestas a un total de 60 personas, pertenecientes a diferentes núcleos familiares del consultorio 70 del policlínico Hermanos Cruz, de la provincia de Pinar del Río, durante el año 2004; una de ellas acerca de los aspectos de la educación bucal, y otra sobre el funcionamiento y estructura familiar, con el objetivo de relacionar el nivel educativo y otros aspectos de la Estomatología con la familia. Se realizó análisis de los datos obtenidos aplicando los métodos de la estadística descriptiva y se detectó un bajo nivel de educación para la salud bucal, al tiempo que pudo comprobarse que existen relaciones entre este aspecto y el tipo de familia, según su estructura y funcionamiento. También pudo comprobarse que no solo reviste importancia el conocimiento que se tenga sobre determinado aspecto, sino que lo que sí resulta fundamental es su aplicación en la práctica(AU)


Subject(s)
Oral Hygiene/education , National Health Strategies
17.
Cochabamba; s.n; s.f. 52 p. tab, graf.
Non-conventional in Spanish | LILACS | ID: lil-492665
SELECTION OF CITATIONS
SEARCH DETAIL
...